Skip to main content
NAGE logo

NAGE · Niagen Bioscience, Inc. · Share Buybacks

Track NAGE — free
$1.86 -0.08 (-4.12%) Play latest call Q3 2026 earnings call transcript
Market Cap
$148.10M
Shares
79.20M
Volume · Nov 19 490.98K Avg daily vol (3M) 506.37K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$20,000,000
as of 2026-05-06 · from Press release (reviewed)
Remaining Authorization
$14,600,000
as of 2026-09-30
Program Utilization
27.0% $5,400,000 used of $20,000,000
Program Announced Authorized Remaining Runs Through
2026-03-19 $20,000,000 $17,400,000 2027-10-31
— $10,000,000 — —

Cash spent on buybacks by quarter

Cash deployed each quarter, with the average price paid where the company reported it. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-09-30 YTD $5,121,000
2025-12-31 $251,000
2024-12-31 $0
2018-12-31 $404,000
2017-12-30 $0
2012-12-29 $-8,200
Key facts CIK 1386570 CUSIP 171077407 13F (30d) 129 filings 116 filers Visit website Investor relations